Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...
Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult times.
Partner with Duke’s Fuqua School of Business to design a custom executive education program aligned with your organization’s ...
Seasoned Executive Brings Three Decades of Oncology and Cell Therapy Leadership from Pfizer, Novartis, and Bayer ATLANTA, Dec. 10, 2025 /PRNewswire/ -- Expression Therapeutics, Inc., a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results